PHARMACOKINETIC DETERMINANTS OF CYCLOSPORINE AND PREDNISONE IN RENAL-TRANSPLANT PATIENTS

[1] PHARMACODYNAMICS OF CYCLOSPORINE-KETOCONAZOLE INTERACTION IN MICE - COMBINED THERAPY POTENTIATES CYCLOSPORINE IMMUNOSUPPRESSION AND TOXICITY [J]. TRANSPLANTATION, 1987, 43 (04) : 529 - 533

[2] ANDERSON JE, 1985, J PHARMACOL EXP THER, V236, P671

[3] ATKINSON K, 1984, BRIT J HAEMATOL, V56, P223, DOI 10.1111/j.1365-2141.1984.tb03950.x

[4] ATKINSON K, 1983, TRANSPLANT P, V15, P2446

[5] PREDNISOLONE AND METHYLPREDNISOLONE KINETICS IN CHILDREN RECEIVING ANTICONVULSANT THERAPY [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1987, 42 (04) : 424 - 432

[6] BEHM HL, 1979, RES COMMUN CHEM PATH, V26, P145

[7] PHARMACOKINETICS AND PROTEIN-BINDING OF PREDNISOLONE IN PATIENTS WITH NEPHROTIC SYNDROME AND PATIENTS UNDERGOING HEMODIALYSIS [J]. KIDNEY INTERNATIONAL, 1983, 23 (06) : 876 - 881

[8] BERGREM H, 1983, ACTA MED SCAND, V213, P333

[9] BERGREM H, 1983, ACTA MED SCAND, V213, P339

[10] BERTAULTPERES P, 1987, DRUG METAB DISPOS, V15, P391

[1] PHARMACODYNAMICS OF CYCLOSPORINE-KETOCONAZOLE INTERACTION IN MICE - COMBINED THERAPY POTENTIATES CYCLOSPORINE IMMUNOSUPPRESSION AND TOXICITY [J]. TRANSPLANTATION, 1987, 43 (04) : 529 - 533

[2] ANDERSON JE, 1985, J PHARMACOL EXP THER, V236, P671

[3] ATKINSON K, 1984, BRIT J HAEMATOL, V56, P223, DOI 10.1111/j.1365-2141.1984.tb03950.x

[4] ATKINSON K, 1983, TRANSPLANT P, V15, P2446

[5] PREDNISOLONE AND METHYLPREDNISOLONE KINETICS IN CHILDREN RECEIVING ANTICONVULSANT THERAPY [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1987, 42 (04) : 424 - 432

[6] BEHM HL, 1979, RES COMMUN CHEM PATH, V26, P145

[7] PHARMACOKINETICS AND PROTEIN-BINDING OF PREDNISOLONE IN PATIENTS WITH NEPHROTIC SYNDROME AND PATIENTS UNDERGOING HEMODIALYSIS [J]. KIDNEY INTERNATIONAL, 1983, 23 (06) : 876 - 881

[8] BERGREM H, 1983, ACTA MED SCAND, V213, P333

[9] BERGREM H, 1983, ACTA MED SCAND, V213, P339

[10] BERTAULTPERES P, 1987, DRUG METAB DISPOS, V15, P391